Evidence map›Paper›PMID 40948698›Full record

ArticleClinical case reports2025

Synchronous Ipsilateral Occurrence of Advanced Renal Pelvic Urothelial Carcinoma With Lung Metastasis and Localized Renal Cell Carcinoma: A Case Report.

Taisuke Okumura, Yuichiro Kato, Akihiro Kojima, Daisuke Kato, Yohei Shimizu, Takeshi Shirakawa, Takumasa Amemiya, Tsunehiro Nenohi, Yuki Matsumoto, Masakazu Nagata and 4 more

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Taisuke OkumuraDepartment of Urology Nissan Tamagawa Hospital Tokyo Japan.ORCID https://orcid.org/0009-0000-5729-1994
Yuichiro KatoDepartment of Urology Kanto Central Hospital Tokyo Japan.
Akihiro KojimaDepartment of Urology Nissan Tamagawa Hospital Tokyo Japan.
Daisuke KatoDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Yohei ShimizuDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Takeshi ShirakawaDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Takumasa AmemiyaDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Tsunehiro NenohiDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Yuki MatsumotoDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Masakazu NagataDepartment of Urology, Showa University School of Medicine Tokyo Japan.
Masayasu UrushibaraDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Mikiko TakahashiDepartment of Diagnostic Pathology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Minato YokoyamaDepartment of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan.
Kazuhiro IshizakaDepartment of Urology Nissan Tamagawa Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The patient was a 92-year-old woman who presented with a complaint of difficulty in urination. Her abdominal computed tomography (CT) revealed two distinct types of tumors in the lower and upper poles of the right kidney, and chest CT revealed multiple lung metastatic tumors. A laparoscopic right radical nephrectomy was performed, and the lower pole tumor was diagnosed as clear cell renal cell carcinoma (RCC), whereas the upper pole tumor was renal pelvic urothelial carcinoma (UC). The lung tumor was diagnosed as metastatic UC via CT-guided biopsy. In this case, histological examination of the primary tumor site resection and immunohistochemical examination of the lung metastases were important in diagnosing metastatic UC. Despite the challenges associated with synchronous RCC and upper tract UC (UTUC), appropriate treatment strategies, including surgical intervention and systemic chemotherapy, may improve prognosis and prolong survival. The findings contribute to the limited knowledge on synchronous RCC and UTUC, offering valuable insights to help clinicians enhance decision-making and improve patient care in similar scenarios.

Indexed as

clear cell renal cell carcinomaenfortumab vedotinlung metastasisrenal pelvic urothelial carcinomasynchronous ipsilateral renal malignanciesupper tract urothelial carcinoma

Identifiers

PMID40948698
PMCPMC12431839

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.